How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation?: Results of a computer simulation
- 31 May 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (5) , 956-965
- https://doi.org/10.1016/s0301-472x(99)00026-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Neutrophil Maturation of CD34+ Cells from Peripheral Blood and Bone Marrow in Serum-Free Culture Medium with PIXY321 and Granulocyte-Colony Stimulating Factor (G-CSF)Journal of Hematotherapy, 1997
- Stem Cell Responses after Radiation ExposureHealth Physics, 1996
- The effect of continuous G‐CSF application in human cyclic neutropenia: a model analysisBritish Journal of Haematology, 1995
- Reduced variance of bone‐marrow transit time of granulopoiesis—a possible pathomechanism of human cyclic neutropeniaCell Proliferation, 1994
- Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatinBritish Journal of Haematology, 1993
- Hematotoxic effects of benzene analyzed by mathematical modelingToxicology, 1992
- A mathematical approach to benzo[a]pyrene-induced hematotoxicityArchives of Toxicology, 1992
- Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesisCell Proliferation, 1990
- THE FATE OF TRANSFUSED H3 THYMIDINE‐LABELED BONE‐MARROW CELLS IN IRRADIATED RECIPIENTS*Annals of the New York Academy of Sciences, 1964
- Quantitative Measurement of Hematopoietic Cells of the Marrow1Journal of Clinical Investigation, 1958